Islet Cell Carcinoma (Endocrine Pancreas... Clinical Trials

• RAD001 plus Depot Octreotide in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma
  ClinicalTrials.gov Identifier: NCT00113360 - Active, not recruiting
  Carcinoma, Neuroendocrine; Carcinoid Tumor; Carcinoma, Islet Cell
  
• Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00003514 - Recruiting
  Merkel Cell Carcinoma; Islet Cell Carcinoma; Neuroendocrine Carcinoma; Pituitary Tumor
  
• A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors.
  ClinicalTrials.gov Identifier: NCT00428597 - Recruiting
  Carcinoma, Islet Cell
  
• Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00227773 - Not yet recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Carcinoma
  
• Sorafenib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00131911 - Active, not recruiting
  Gastrinoma; gastrointestinal carcinoid tumor; Insulinoma; Islet Cell Carcinoma; metastatic gastrointestinal carcinoid tumor; ...
  
• Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00075439 - Active, not recruiting
  Gastrinoma; gastrointestinal carcinoid tumor; Insulinoma; Islet Cell Carcinoma; metastatic gastrointestinal carcinoid tumor; ...
  
• FR901228 in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00084461 - Active, not recruiting
  gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor
  
• Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00027638 - Active, not recruiting
  gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor
  
• CCI-779 in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00093782 - Active, not recruiting
  gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor
  
• Modification of the "Edmonton Protocol" to allow for successful islet transplantation from a single pancreas and extension of the "Edmonton Protocol" to kidney transplant recipients
  ClinicalTrials.gov Identifier: NCT00021580 - Active, not recruiting
  Diabetes Mellitus
  
• Flavopiridol in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00112684 - Recruiting
  gastrointestinal carcinoid tumor; Islet Cell Carcinoma; Pheochromocytoma; Thyroid Cancer
  
• Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00416767 - Active, not recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Neoplastic Syndrome
  
• Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002659 - Active, not recruiting
  recurrent squamous cell carcinoma of the hypopharynx; recurrent squamous cell carcinoma of the larynx; ...
  
• Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003257 - Active, not recruiting
  recurrent squamous cell carcinoma of the hypopharynx; recurrent squamous cell carcinoma of the larynx; ...
  
• Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis
  ClinicalTrials.gov Identifier: NCT00021294 - Active, not recruiting
  actinic keratosis; squamous cell carcinoma of the skin; prevention of skin cancer; basal cell carcinoma of the skin
  
• Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
  ClinicalTrials.gov Identifier: NCT00002506 - Active, not recruiting
  recurrent non-small cell lung cancer; recurrent cervical cancer; recurrent squamous cell carcinoma of the lip and oral cavity; ...
  
• ZD6474 With Radiation or Concomitantly With Weekly Cisplatin and Radiation Therapy, Stage III-IV Head and Neck Squamous Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00411710 - Recruiting
  Head and Neck Squamous Cell Carcinoma; Squamous Cell Carcinoma of the Oral Cavity; Squamous Cell Carcinoma of the Oropharynx; Squamous Cell Carcinoma of the Hypopharynx; Squamous Cell Carcinoma of the Larynx
  
• Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00003856 - Active, not recruiting
  recurrent squamous cell carcinoma of the oropharynx; recurrent squamous cell carcinoma of the hypopharynx; recurrent salivary gland cancer; ...
  
• Pazopanib in Treating Patients With Advanced Neuroendocrine Cancer
  ClinicalTrials.gov Identifier: NCT00454363 - Recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Multiple Endocrine Neoplasia 1 and 2 (men1, men2); Neoplastic Syndrome
  
• Pancreatic Islet Cell Transplantation - A Novel Approach to Immunosuppression
  ClinicalTrials.gov Identifier: NCT00530686 - Recruiting
  Islet Cell Transplantation; Type 1 Diabetes
  
• Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004246 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage IVA squamous cell carcinoma of the nasopharynx; ...
  
• Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00002670 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity; ...
  
• High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002555 - Active, not recruiting
  stage III squamous cell carcinoma of the lip and oral cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00054054 - Active, not recruiting
  stage III squamous cell carcinoma of the hypopharynx; stage III squamous cell carcinoma of the larynx; ...
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003888 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage III squamous cell carcinoma of the hypopharynx; ...
  
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00005814 - Active, not recruiting
  stage III squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; ...
  
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00113399 - Active, not recruiting
  recurrent squamous cell carcinoma of the hypopharynx; recurrent squamous cell carcinoma of the larynx; ...
  
• Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002654 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage III squamous cell carcinoma of the hypopharynx; ...
  
• DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003951 - Active, not recruiting
  recurrent pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage IV pancreatic cancer; adenocarcinoma of the pancreas
  
• CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas
  ClinicalTrials.gov Identifier: NCT00540579 - Not yet recruiting
  Pancreas
  
• Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00004226 - Active, not recruiting
  recurrent squamous cell carcinoma of the lip and oral cavity; recurrent squamous cell carcinoma of the hypopharynx; ...
  
• Capecitabine in Treating Patients With Locally Recurrent or Metastatic Nasopharygeal Cancer
  ClinicalTrials.gov Identifier: NCT00095901 - Active, not recruiting
  recurrent squamous cell carcinoma of the nasopharynx; stage IV squamous cell carcinoma of the nasopharynx; ...
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004094 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage IV squamous cell carcinoma of the nasopharynx; ...
  
• Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00002932 - Active, not recruiting
  stage IV squamous cell carcinoma of the larynx; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00011999 - Active, not recruiting
  stage III squamous cell carcinoma of the lip and oral cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced or Regional Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00096174 - Active, not recruiting
  stage IV squamous cell carcinoma of the hypopharynx; stage IV squamous cell carcinoma of the larynx; ...
  
• Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases
  ClinicalTrials.gov Identifier: NCT00019786 - Active, not recruiting
  Colorectal Cancer; Islet Cell Tumor; Liver Cancer; Metastatic Cancer; Neuroendocrine Carcinoma
  
• Combination Chemotherapy and Radiation Therapy In Treating Patients With Stage III or Stage IV Cancer of the Hypopharynx or Tongue
  ClinicalTrials.gov Identifier: NCT00002735 - Active, not recruiting
  stage III squamous cell carcinoma of the hypopharynx; stage III squamous cell carcinoma of the oropharynx; ...
  
• Biobank Pancreas Carcinoma
  ClinicalTrials.gov Identifier: NCT00157404 - Recruiting
  Pancreas Cancer
  
• Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003592 - Active, not recruiting
  stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• SU011248 in the Treatment of Patients with Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00089648 - Active, not recruiting
  Renal Cell Carcinoma
  
• Panitumumab Plus Chemoradiotherapy and Induction Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00513383 - Recruiting
  Squamous Cell Carcinoma of the Head and Neck; Basaloid Squamous Cell Carcinoma; Undifferentiated Carcinoma; Adenosquamous Cell Carcinoma
  
• Islet Cell Transplant
  ClinicalTrials.gov Identifier: NCT00160732 - Recruiting
  Diabetes Mellitus, Type 1
  
• Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA
  ClinicalTrials.gov Identifier: NCT00006431 - Active, not recruiting
  Renal Cell Carcinoma
  
• Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003328 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage III squamous cell carcinoma of the hypopharynx; ...
  
• Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00003200 - Active, not recruiting
  stage III squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; ...
  
• SU011248 in the Treatment of Patients with Cytokine-Refractory Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00077974 - Active, not recruiting
  Renal Cell Carcinoma
  
• Treatment Protocol for the use of Sorafenib in Patients with Advanced Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00111020 - Active, not recruiting
  Renal Cell Carcinoma
  
• A Study of Motexafin Gadolinium (MGd) in Combination with Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00102505 - Active, not recruiting
  Non-Small-Cell Lung Carcinoma; Carcinoma, Bronchogenic
  
• A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers
  ClinicalTrials.gov Identifier: NCT00122239 - Recruiting
  -breast carcinoma; -glioma; -prostate carcinoma; -squamous cell carcinoma of the head and neck; -lung carcinoma (non-small cell)
  
• Multimodality Treatment for Patients with Resectable NSCLC-BEACON Study: Bevacizumab+Chemotherapy for Operable NSCLC
  ClinicalTrials.gov Identifier: NCT00130780 - Recruiting
  Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell
  
• Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients with Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00082459 - Active, not recruiting
  Renal Cell Carcinoma
  
• GW786034 In Subjects With Locally Recurrent Or Metastatic Clear Cell Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00244764 - Active, not recruiting
  Renal Cell Carcinoma; Solid Tumors
  
• Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00058201 - Recruiting
  acinar cell adenocarcinoma of the pancreas; duct cell adenocarcinoma of the pancreas; stage I pancreatic cancer; stage II pancreatic cancer; ...
  
• Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx
  ClinicalTrials.gov Identifier: NCT00002839 - Active, not recruiting
  stage II squamous cell carcinoma of the hypopharynx; stage III squamous cell carcinoma of the hypopharynx; ...
  
• Optical Biopsy of Human Skin in Conjunction With Laser Treatment
  ClinicalTrials.gov Identifier: NCT00540566 - Enrolling by invitation
  Malignant Melanoma,; Merkel Cell Carcinoma,; Basal Cell Carcinoma,; Squamous Cell Carcinoma; Atypical Nevi,; Congenital Nevi; Seborrheic Keratosis,; Paget's Disease; Dermatofibroma,; Kaposi's Sarcoma; Hypervascular Congenital Malformations; Port Wine Stain; Hemangioma; Tattoos; Scleroderma; Burns; Normal Skin
  
• Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00002493 - Active, not recruiting
  stage III endometrial cancer; stage IV endometrial cancer; endometrial clear cell carcinoma; endometrial adenosquamous cell carcinoma; ...
  
• Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00227617 - Recruiting
  Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Neoplastic Syndrome; Neuroendocrine Carcinoma of the Skin
  
• Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00570674 - Recruiting
  Squamous Cell Carcinoma of the Head and Neck; Basaloid Squamous Cell Carcinoma; Undifferentiated Carcinoma; Adenosquamous Cell Carcinoma
  
• Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer
  ClinicalTrials.gov Identifier: NCT00049166 - Active, not recruiting
  stage II squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the oropharynx; ...
  
• Using the Bioelectric Field Imager for Diagnosing Skin Cancer
  ClinicalTrials.gov Identifier: NCT00391300 - Active, not recruiting
  Basal Cell Carcinoma; Squamous Cell Carcinoma; Melanoma
  
• Study of EKB-569 in Subjects with Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00067548 - Active, not recruiting
  Non-Small-Cell Lung Carcinoma; Carcinoma, Non-Small Cell Lung
  
• Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin
  ClinicalTrials.gov Identifier: NCT00022178 - Active, not recruiting
  squamous cell carcinoma of unknown primary; newly diagnosed carcinoma of unknown primary; undifferentiated carcinoma of unknown primary; ...
  
• Islet Cell Transplants for Diabetes
  ClinicalTrials.gov Identifier: NCT00014911 - Active, not recruiting
  Diabetes Mellitus, Insulin-Dependent
  
• Laser Surgery Plus Radiation Therapy in Treating Patients With Early Stage Cancer of the Larynx
  ClinicalTrials.gov Identifier: NCT00003040 - Active, not recruiting
  stage II squamous cell carcinoma of the larynx; stage III squamous cell carcinoma of the larynx; stage I squamous cell carcinoma of the larynx
  
• Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx
  ClinicalTrials.gov Identifier: NCT00002496 - Active, not recruiting
  stage III squamous cell carcinoma of the larynx; stage IV squamous cell carcinoma of the larynx
  
• Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant
  ClinicalTrials.gov Identifier: NCT00001859 - Recruiting
  Diabetes Mellitus; Kidney Failure
  
• Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx
  ClinicalTrials.gov Identifier: NCT00003627 - Active, not recruiting
  stage III squamous cell carcinoma of the hypopharynx; stage III squamous cell carcinoma of the oropharynx; ...
  
• SU011248 versus Interferon-alfa as First-Line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00083889 - Active, not recruiting
  Renal Cell Carcinoma
  
• Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion in Patients with Pulmonary and Pleural Malignancies
  ClinicalTrials.gov Identifier: NCT00037817 - Recruiting
  Small Cell Carcinoma; Mesothelioma; Non-Small-Cell Lung Carcinoma
  
• Sorafenib and Interferon alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00098618 - Active, not recruiting
  recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma; renal granular cell carcinoma
  
• Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer
  ClinicalTrials.gov Identifier: NCT00005884 - Active, not recruiting
  prevention of skin cancer; basal cell carcinoma of the skin; squamous cell carcinoma of the skin
  
• Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00002747 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity; ...
  
• Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
  ClinicalTrials.gov Identifier: NCT00568906 - Recruiting
  Carcinoma, Giant Cell; Carcinoma, Non-Small-Cell Lung
  
• Study of Radiation Dose Intensity Concurrent with Chemotherapy For Limited Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00126828 - Active, not recruiting
  Carcinoma, Small Cell
  
• Combination Chemotherapy in Patients with Zollinger-Ellison Syndrome and tumors of the pancreas
  ClinicalTrials.gov Identifier: NCT00001165 - Completed
  Islet Cell Adenoma; Neoplasm Metastasis; Zollinger Ellison Syndrome
  
• Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00003127 - Active, not recruiting
  endometrial adenosquamous cell carcinoma; endometrial adenocarcinoma; stage IV endometrial cancer; endometrial clear cell carcinoma; ...
  
• Pancreatic Islet Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00214786 - Recruiting
  Islet Cell Transplantation
  
• Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00095186 - Active, not recruiting
  Carcinoma, Renal Cell
  
• Trial of BAY 43-9006 in Patients with Relapsed or Refractory Advanced Non-Small Cell Lung Carcinoma
  ClinicalTrials.gov Identifier: NCT00101413 - Active, not recruiting
  Non-small cell lung carcinoma
  
• Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer
  ClinicalTrials.gov Identifier: NCT00014118 - Active, not recruiting
  stage III squamous cell carcinoma of the oropharynx; stage IV squamous cell carcinoma of the oropharynx; ...
  
• Study to Evaluate Safety and Biological Activity of TroVax® Vaccine Given in Conjunction With IL-2 to Treat Locally Advanced or Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00325507 - Active, not recruiting
  Carcinoma, Renal Cell
  
• Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00217633 - Recruiting
  cervical adenocarcinoma; cervical adenosquamous cell carcinoma; cervical small cell carcinoma; cervical squamous cell carcinoma; ...
  
• Low Fat Diet to Prevent Disease Progression in Patients With Skin Cancer
  ClinicalTrials.gov Identifier: NCT00003097 - Active, not recruiting
  squamous cell carcinoma of the skin; prevention of skin cancer; basal cell carcinoma of the skin
  
• Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00042926 - Active, not recruiting
  stage I squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity
  
• Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00095641 - Not yet recruiting
  recurrent squamous cell carcinoma of the lip and oral cavity; recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity; ...
  
• Study of SU011248 in Combination with Gefitinib in Patients with Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00113529 - Active, not recruiting
  Renal Cell Carcinoma
  
• Hardwins - Squamous Cell Carcinoma Head & Neck (Surgery/RT)
  ClinicalTrials.gov Identifier: NCT00188318 - Active, not recruiting
  Carcinoma, Squamous Cell
  
• A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00189241 - Active, not recruiting
  Basal Cell Carcinoma
  
• Non-small Cell Lung Cancer Study US75 (Z-PACT)
  ClinicalTrials.gov Identifier: NCT00086268 - Active, not recruiting
  Non Small Cell Lung Carcinoma
  
• Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003139 - Active, not recruiting
  oral complications of cancer and cancer therapy; oropharyngeal squamous cell carcinoma; lip and oral cavity squamous cell carcinoma
  
• Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
  ClinicalTrials.gov Identifier: NCT00064077 - Active, not recruiting
  cervical adenocarcinoma; cervical adenosquamous cell carcinoma; cervical squamous cell carcinoma; recurrent cervical cancer; ...
  
• Treatment Use Study with Sunitinib (SU011248) for Patients with Cytokine-Refractory Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00130897 - Recruiting
  Carcinoma, Renal Cell
  
• Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00265941 - Recruiting
  Stage III Squamous Cell Carcinoma of the Hypopharynx; Stage IV Squamous Cell Carcinoma of the Hypopharynx; ...
  
• Non-small Cell Lung Cancer Refractory to Platinum-based Therapy
  ClinicalTrials.gov Identifier: NCT00063219 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Celecoxib in Preventing Skin Cancer
  ClinicalTrials.gov Identifier: NCT00025051 - Recruiting
  basal cell carcinoma of the skin; squamous cell carcinoma of the skin
  
• Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00057785 - Active, not recruiting
  oral complications of chemotherapy and head/neck radiation; radiation toxicity; stage I squamous cell carcinoma of the nasopharynx; ...
  
• Cediranib (AZD2171, RECENTINTM) in Metastatic or Recurrent Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00423332 - Active, not recruiting
  Renal Cell Carcinoma
  
• Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00003209 - Active, not recruiting
  cervical squamous cell carcinoma; cervical adenocarcinoma; stage IB cervical cancer; stage IIA cervical cancer; cervical adenosquamous cell carcinoma
  
• Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients with Advanced/Metastatic Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00112294 - Active, not recruiting
  Non-Small-Cell Lung Carcinoma